3933 — United Laboratories International Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
HK$25.93bn
Enterprise Value
HK$21.73bn
Revenue
CNY13.76bn

Annual balance sheet for United Laboratories International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	2,997	3,331	4,743	4,262	6,330
Net Total Accounts Receivable
Net Total Receivables	3,359	3,800	4,912	6,314	6,272
Total Inventory
Total Other Current Assets
Total Current Assets	8,225	9,986	12,515	13,787	16,071
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,389	6,131	6,266	7,004	9,459
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	14,964	16,331	18,980	21,017	25,833
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,860	6,535	7,033	6,627	8,773
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	6,350	6,991	8,372	8,282	11,445
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	8,614	9,340	10,608	12,735	14,388
Total Liabilities & Shareholders' Equity	14,964	16,331	18,980	21,017	25,833
Total Common Shares Outstanding